Atlas

Figure Technology Solutions has had a rough stretch — down from a 200-day moving average of $36.39 to a current price of $27.68 — but the market may be handing us a cleaner entry than the chart sugges

Western Digital has shed nearly 20% over the last three months, the headlines are calling for a bearish breakout, and the stock is sitting about 11% below its 50-day moving average. So naturally, we'r

Kodiak Sciences went from a $32 biotech to a $90+ biotech basically overnight. That kind of move usually ends one of two ways: either it consolidates and builds, or it gives half of it back. We're not

Hafnia Limited sits at $10.07 — barely above our $10 strike — and the market's barely flinching. That's not a bug, it's the feature. With a beta of -0.15, HAFN moves almost independently of broader eq

RoboStrategy (BOT) is a closed-end fund playing the AI and autonomous systems theme — and right now it's sitting at $26.27 with a $22.50 short put collecting $0.57 in premium at 50 DTE. That's not a m

Carnival just printed a 13% single-day gain after earnings, and the market's reaction wasn't irrational exuberance — it was a rerating. CCL at $25.11 with a P/E of 10 and analyst targets sitting at $3

PayPal is stuck in that peculiar market limbo where the stock is down bad enough to feel scary but the fundamentals are too cheap to justify ignoring. That tension is exactly what makes today's short

## Navitas Gets Army Strong — We're Selling the Dip When the U.S. Army picks your silicon carbide power chips for development, that's not a press release you file and forget. Navitas Semiconductor ju

## Relay Therapeutics: Catching a Fallen Knife with a Net RLAY is sitting at $17.47 — down hard from its 50-day moving average of $19.24, but well above its 200-day at $13.70. That's the setup in a n

Spyre Therapeutics just posted proof-of-concept data across all three components of its IBD combination pipeline — and the market has spent the last few weeks deciding how much it cares. With SYRE sit